Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-05 Sale | 2025-06-06 5:58 pm | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 3 | $30.48 | $91 | 26,798 (Direct) | View |
| 2025-01-23 Sale | 2025-01-27 8:28 pm | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 55,000 | $40.25 | $2,213,997 | 100,700 (Indirect Direct) | View |
| 2024-12-18 Sale | 2024-12-19 6:57 pm | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 18,709 | $41.21 | $770,912 | 6,000 (Direct) | View |
| 2024-11-22 Sale | 2024-11-22 7:48 pm | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 4,891 | $41.08 | $200,947 | 28,475 (Indirect Direct) | View |
| 2024-03-08 Sale | 2024-03-11 8:09 pm | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 2,092 | $45.69 | $95,583 | 16,500 (Direct) | View |
| 2024-03-07 Sale | 2024-03-08 5:31 pm | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation | 7,137 | $46.28 | $330,290 | 8,398 (Direct) | View |
| 2024-03-07 Sale | 2024-03-08 5:28 pm | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 13,000 | $46.28 | $601,615 | 2,000 (Direct) | View |
| 2023-12-14 Sale(A) | 2023-12-15 9:50 pm | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 7,598 | $41.05 | $311,898 | 4,902 (Indirect) | View |
| 2023-12-13 Sale | 2023-12-15 5:38 pm | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 18,978 | $39.99 | $758,983 | 28,475 (Indirect Direct) | View |
| 2023-08-24 Sale | 2023-08-24 4:33 pm | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 25,000 | $38.7 | $967,500 | 25,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-05 Option Award | 2025-06-06 6:00 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 6:00 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:59 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:59 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:58 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 19,657 | $0 | 26,798 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:57 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:57 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 5:59 pm | N/A 2025-05-20 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 5,144 | $0 | 7,144 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 5:59 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 5,144 | $12.57 | 7,144 (Direct) | View |
| 2025-03-12 Option Award | 2025-03-13 7:33 pm | N/A 2035-03-11 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2025-03-12 Option Award | 2025-03-13 7:31 pm | N/A 2035-03-11 | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2025-03-12 Option Award | 2025-03-13 7:30 pm | N/A 2035-03-11 | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-27 8:28 pm | N/A 2025-03-16 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 55,000 | $0 | 100,700 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-27 8:28 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 55,000 | $17.76 | 100,700 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-19 6:57 pm | N/A 2029-09-15 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 25,334 | $0 | 6,000 (Direct) | View |
| 2024-12-18 Tax Withholding | 2024-12-19 6:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 6,625 | $41.28 | 6,000 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-19 6:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 9,334 | $9.44 | 6,000 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-19 6:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 16,000 | $11.58 | 6,000 (Direct) | View |
| 2024-11-22 Tax Withholding | 2024-11-22 7:48 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 1,695 | $39.8 | 28,475 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-22 7:48 pm | N/A 2026-06-01 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 6,586 | $0 | 28,475 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-22 7:48 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 3,500 | $7.38 | 28,475 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-22 7:48 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 3,086 | $13.48 | 28,475 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:43 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:41 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:41 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:42 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:41 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:38 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:37 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:35 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:34 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-12 6:33 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-11 8:09 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 3,500 | $0 | 16,500 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:09 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 1,408 | $46.16 | 16,500 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-11 8:09 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 3,500 | $18.56 | 16,500 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-08 5:31 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation | 8,641 | $9.85 | 8,398 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-08 5:31 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation | 1,504 | $45.96 | 8,398 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-08 5:31 pm | N/A 2024-03-11 | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation | 8,641 | $0 | 8,398 (Direct) | View |
| 2023-12-29 Other | 2024-01-02 4:41 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation | 8,398 | $0 | 16,796 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-20 5:04 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 4,320 | $9.85 | 74,225 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-20 5:04 pm | 2016-12-31 2024-01-13 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 4,320 | $0 | 74,225 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 5:38 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 9,258 | $9.85 | 28,475 (Direct) | View |
| 2023-12-13 Tax Withholding | 2023-12-15 5:38 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 3,022 | $39.68 | 28,475 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 5:38 pm | 2016-12-31 2024-01-13 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 14,322 | $0 | 28,475 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 5:38 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 5,144 | $9 | 28,475 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-10 7:05 pm | N/A 2033-08-09 | Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director | 28,000 | $0 | 28,000 (Direct) | View |
Ownership | 2023-08-10 7:00 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Gover Justin D. Director | 0 | $0 | 0 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-10 6:56 pm | N/A 2033-08-09 | Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director | 28,000 | $0 | 28,000 (Direct) | View |
Ownership | 2023-08-10 6:40 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Cannon Gillian Director | 0 | $0 | 0 (Direct) | View |